These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 19782806)

  • 1. Multi-target spectral moment: QSAR for antiviral drugs vs. different viral species.
    Prado-Prado FJ; Borges F; Uriarte E; Peréz-Montoto LG; González-Díaz H
    Anal Chim Acta; 2009 Oct; 651(2):159-64. PubMed ID: 19782806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-target spectral moment: QSAR for antifungal drugs vs. different fungi species.
    Prado-Prado FJ; Borges F; Perez-Montoto LG; González-Díaz H
    Eur J Med Chem; 2009 Oct; 44(10):4051-6. PubMed ID: 19467743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
    Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unify QSAR approach to antimicrobials. Part 1: predicting antifungal activity against different species.
    González-Díaz H; Prado-Prado FJ; Santana L; Uriarte E
    Bioorg Med Chem; 2006 Sep; 14(17):5973-80. PubMed ID: 16759868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-target spectral moments for QSAR and Complex Networks study of antibacterial drugs.
    Prado-Prado FJ; Uriarte E; Borges F; González-Díaz H
    Eur J Med Chem; 2009 Nov; 44(11):4516-21. PubMed ID: 19631422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Prado-Prado FJ; García-Mera X; González-Díaz H
    Bioorg Med Chem; 2010 Mar; 18(6):2225-2231. PubMed ID: 20185316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR for anti-RNA-virus activity, synthesis, and assay of anti-RSV carbonucleosides given a unified representation of spectral moments, quadratic, and topologic indices.
    González-Díaz H; Cruz-Monteagudo M; Viña D; Santana L; Uriarte E; De Clercq E
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1651-7. PubMed ID: 15745816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unified QSAR & network-based computational chemistry approach to antimicrobials. II. Multiple distance and triadic census analysis of antiparasitic drugs complex networks.
    Prado-Prado FJ; Ubeira FM; Borges F; González-Díaz H
    J Comput Chem; 2010 Jan; 31(1):164-73. PubMed ID: 19421992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.
    Prado-Prado F; García-Mera X; Escobar M; Sobarzo-Sánchez E; Yañez M; Riera-Fernandez P; González-Díaz H
    Eur J Med Chem; 2011 Dec; 46(12):5838-51. PubMed ID: 22005185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica.
    Prado-Prado F; García-Mera X; Abeijón P; Alonso N; Caamaño O; Yáñez M; Gárate T; Mezo M; González-Warleta M; Muiño L; Ubeira FM; González-Díaz H
    Eur J Med Chem; 2011 Apr; 46(4):1074-94. PubMed ID: 21315497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.
    González-Díaz H; Prado-Prado F; Sobarzo-Sánchez E; Haddad M; Maurel Chevalley S; Valentin A; Quetin-Leclercq J; Dea-Ayuela MA; Teresa Gomez-Muños M; Munteanu CR; José Torres-Labandeira J; García-Mera X; Tapia RA; Ubeira FM
    J Theor Biol; 2011 May; 276(1):229-49. PubMed ID: 21277861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unified QSAR approach to antimicrobials. Part 2: predicting activity against more than 90 different species in order to halt antibacterial resistance.
    Prado-Prado FJ; González-Díaz H; Santana L; Uriarte E
    Bioorg Med Chem; 2007 Jan; 15(2):897-902. PubMed ID: 17084086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple stochastic fingerprints towards mathematical modeling in biology and medicine 2. Unifying Markov model for drugs side effects.
    Cruz-Monteagudo M; González-Díaz H; Uriarte E
    Bull Math Biol; 2006 Oct; 68(7):1527-54. PubMed ID: 16847720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting antitrichomonal activity: a computational screening using atom-based bilinear indices and experimental proofs.
    Marrero-Ponce Y; Meneses-Marcel A; Castillo-Garit JA; Machado-Tugores Y; Escario JA; Barrio AG; Pereira DM; Nogal-Ruiz JJ; Arán VJ; Martínez-Fernández AR; Torrens F; Rotondo R; Ibarra-Velarde F; Alvarado YJ
    Bioorg Med Chem; 2006 Oct; 14(19):6502-24. PubMed ID: 16875830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices.
    Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Sultan S; Torrens F; Rotondo R
    Bioorg Med Chem; 2007 Feb; 15(3):1483-503. PubMed ID: 17110117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting multiple drugs side effects with a general drug-target interaction thermodynamic Markov model.
    González-Díaz H; Cruz-Monteagudo M; Molina R; Tenorio E; Uriarte E
    Bioorg Med Chem; 2005 Feb; 13(4):1119-29. PubMed ID: 15670920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HP-Lattice QSAR for dynein proteins: experimental proteomics (2D-electrophoresis, mass spectrometry) and theoretic study of a Leishmania infantum sequence.
    Dea-Ayuela MA; Pérez-Castillo Y; Meneses-Marcel A; Ubeira FM; Bolas-Fernández F; Chou KC; González-Díaz H
    Bioorg Med Chem; 2008 Aug; 16(16):7770-6. PubMed ID: 18662882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dragon method for finding novel tyrosinase inhibitors: Biosilico identification and experimental in vitro assays.
    Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Khan KM; Torrens F; Rotondo R
    Eur J Med Chem; 2007; 42(11-12):1370-81. PubMed ID: 17637486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the anticancer activity of nucleoside analogues: a QSAR model approach using an internally consistent training set.
    Helguera AM; Rodríguez-Borges JE; García-Mera X; Fernández F; Cordeiro MN
    J Med Chem; 2007 Apr; 50(7):1537-45. PubMed ID: 17341060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.